![Andrew Hirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Hirsch
Amministratore Delegato presso
C4 THERAPEUTICS, INC.
Patrimonio netto: 455 386 $ in data 30/09/2026
Profilo
Andrew J.
Hirsch is President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
Mr. Hirsch is an Independent Director at Editas Medicine, Inc. since 2017.
Formerly, Mr. Hirsch was CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2018 to 2020.
Mr. Hirsch was President, CEO, CAO & Director at DNIB Unwind, Inc. in 2016.
Mr. Hirsch was Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch was VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011.
Mr. Hirsch completed undergraduate studies at the University of Pennsylvania in 1992.
Mr. Hirsch earned an MBA from Tuck School of Business at Dartmouth in 1997.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/04/2026 | 135.209 ( 0,11% ) | 450 246 $ | 30/09/2026 | |
| 17/06/2026 | 2.000 ( 0% ) | 5 140 $ | 30/09/2026 |
Posizioni attive di Andrew Hirsch
| Società | Posizione | Inizio |
|---|---|---|
| EDITAS MEDICINE, INC. | Direttore/Membro del Consiglio | 30/05/2017 |
| C4 THERAPEUTICS, INC. | Amministratore Delegato | 02/10/2020 |
Precedenti posizioni note di Andrew Hirsch
| Società | Posizione | Fine |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 11/09/2020 |
| DNIB UNWIND INC | Amministratore Delegato | 24/07/2016 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Direttore Finanziario/CFO | 31/03/2012 |
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2011 |
Formazione di Andrew Hirsch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
